| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
3
2
5
1
1
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Performance
The fund makes the list of Zacks Investment Research's "Top 5 Eaton Vance Funds." Funds on the list are expected to outperform their peers in the future.
Zacks Investment Research 2010-04-23
Hypothetical Growth of $10,000
Updated 04.30.2013
Trailing Total Returns
Updated 04.30.2013
| Total Return % | + / - MSCI World NR USD | + / - DJ US Health Care TR USD | % Rank | |
|---|---|---|---|---|
| Year-to-date | 18.50 | 7.38 | -1.35 | 66 |
| 1-Month | 3.16 | 0.01 | -0.13 | 67 |
| 3-Month | 11.18 | 5.44 | -0.26 | 50 |
| 6-Month | 17.42 | 2.75 | -3.13 | 83 |
| 1-Year | 22.14 | 5.44 | -8.10 | 83 |
| 3-Year (Annualized) | 13.67 | 4.08 | -4.54 | 82 |
| 5-Year (Annualized) | 11.27 | 9.45 | -0.40 | 49 |
| 10-Year (Annualized) | 9.34 | 1.05 | 0.49 | 62 |
